In evidence

Thursday, 16 May, 2019
English
The co-existence of impaired bone health (osteopenia/osteoporosis), reduced muscle mass and strength (sarcopenia), and increased adiposity (obesity) in middle-aged and older people has been identified in recent studies, leading to a proposal for the existence of "osteosarcopenic obesity" as a distinct entity.

Tuesday, 22 January, 2019
English
An appropriate consumption of proteins with the usual diet is important to muscle mass maintenance as it guarantees the right amount of essential amino acids and consequently stimulates protein synthesis.

Friday, 12 July, 2019
English
Recent definitions of malnutrition include low muscle mass within its diagnostic criteria. In fact, malnutrition is one of the main risk factors of skeletal muscle loss contributing to the onset of sarcopenia.

Monday, 13 May, 2019
English
in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia.

Friday, 12 July, 2019
English
People with Down syndrome (DS) experience premature aging. Whether this accelerated aging also involves early declines in muscle mass, strength and physical performance is presently unclear.

Tuesday, 6 November, 2018
English
HMB to support muscle health HMB is a metabolite of leucine, a branched-chain essential amino acid exclusively obtained from dietary sources...

Wednesday, 11 July, 2018
English
The importance of physical activity There is increasing evidence of the beneficial effects of regular physical activity in all age groups. Older people suffering from chronic diseases should also engage in an activity compatible with their physical abilities and conditions. Regular physical activity increases the average life expectancy by inhibiting the development of chronic diseases, mitigating age-related biological changes and their consequences on health and helping to preserve functional capacity. A targeted exercise program is able to influence the aging process through its impact on physiological processes, the evolution of chronic diseases and disabling conditions.

Wednesday, 11 July, 2018
English
Over the years, the role of nutrition to be active and healthy becomes increasingly important. A balanced diet combined with a healthy lifestyle plays a fundamental role in preventing diseases, in particular cardiovascular diseases, some types of cancer, and in preserving the psychophysical efficiency of our body. A correct and balanced diet, in fact, is essential to maintain a good state of health and greater efficiency of the organism.

Wednesday, 2 May, 2018
English
As the first update of 2018, the Glisten group wants to highlight the importance of sarcopenia in the hospital. Two recent studies, the result of research by the GLISTEN group, have shown how the problem of sarcopenia is significant in the hospital, both in terms of prevalence at the time of admission, and incidence during the days of hospitalization.

Wednesday, 30 March, 2016
English
Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial Nicolaas E. Deutz et al. on behalf of the NOURISH Study Group (Riammissione e mortalità in pazienti anziani malnutriti e ricoverati trattati con un supplemento nutrizionale orale specifico: uno studio clinico randomizzato Nicolaas E. Deutz et al. per conto del Gruppo di Studio NOURISH) In this multicenter, controlled and randomized clinical study, recently published online in Clinical Nutrition, the authors evaluated the effect of a high-protein oral nutritional supplement (ONS) with HMB (active leucine metabolite) in a sample of older hospitalized individuals suffering from clinically evident malnutrition (class B and C to the Subjective Global Assessment -SGA). The sample of subjects enrolled in this study had one of the following diagnoses at the time of admission to the hospital: myocardial infarction, congestive heart failure, pneumonia, and chronic obstructive pulmonary disease. The efficacy of the ONS with HMB was evaluated considering the incidence of mortality and the new admission to hospital during the three months following discharge.